Optimal management of infrainguinal arterial occlusive disease

References

• SelvinEErlingerTPPrevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000Circulation2004110673874315262830
   PubMed Web of Science ®Google Scholar
• NorgrenLHiattWRDormandyJANehlerMRHarrisKAFowkesFGTASC II Working GroupInter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)J Vasc Surg200745Suppl SS5S6717223489
   PubMed Web of Science ®Google Scholar
• GoASMozaffarianDRogerVLAmerican Heart Association Statistics Committee and Stroke Statistics SubcommitteeExecutive summary: heart disease and stroke statistics – 2014 update: a report from the American Heart AssociationCirculation2014129339941024446411
   PubMed Web of Science ®Google Scholar
• BhattDLStegPGOhmanEMREACH Registry InvestigatorsInternational prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosisJAMA2006295218018916403930
   PubMed Web of Science ®Google Scholar
• MurabitoJMEvansJCLarsonMGNietoKLevyDWilsonPWFramingham StudyThe ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham StudyArch Intern Med2003163161939194212963567
   PubMedGoogle Scholar
• HirschATCriquiMHTreat-JacobsonDPeripheral arterial disease detection, awareness, and treatment in primary careJAMA2001286111317132411560536
   PubMed Web of Science ®Google Scholar
• HirschATHaskalZJHertzerNRAmerican Association for Vascular SurgerySociety for Vascular SurgerySociety for Cardiovascular Angiography and InterventionsSociety for Vascular Medicine and BiologySociety of Interventional RadiologyACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial DiseaseAmerican Association of Cardiovascular and Pulmonary RehabilitationNational Heart, Lung, and Blood InstituteSociety for Vascular NursingTransAtlantic Inter-Society ConsensusVascular Disease FoundationACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease FoundationCirculation200611311e463e65416549646
   PubMed Web of Science ®Google Scholar
• FowkesGRHousleyERiemersaRASmoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery StudyAm J Epidemiol199213543313401550087
   PubMed Web of Science ®Google Scholar
• SelvinEMarinopoulosSBerkenblitGMeta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitusAnn Intern Med2004141642143115381515
   PubMed Web of Science ®Google Scholar
• MurabitoJMD’AgostinoRBSilbershatzHWilsonWFIntermittent claudication. A risk profile from The Framingham Heart StudyCirculation199796144499236415
   PubMed Web of Science ®Google Scholar
• O’HareAMVittinghoffEHsiaJShlipakMGRenal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS)J Am Soc Nephrol20041541046105115034108
   PubMed Web of Science ®Google Scholar
• RidkerPMStampferMJRifaiNNovel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial diseaseJAMA2001285192481248511368701
   PubMed Web of Science ®Google Scholar
• MulukSCMulukVSKelleyMEOutcome events in patients with claudication: a 15-year study in 2777 patientsJ Vasc Surg2001332251257 discussion 257–25811174775
   PubMed Web of Science ®Google Scholar
• Long-term mortality and its predictors in patients with critical limb ischaemiaThe ICAI Group (Gruppo di Studio dell’Ischemia Cronica Critica degli Arti Inferiori). The Study Group of Critical Chronic Ischemia of the Lower ExtremityEur J Vasc Endovasc Surg199714291959314849
   PubMedGoogle Scholar
• MarstonWADaviesSWArmstrongBNatural history of limbs with arterial insufficiency and chronic ulceration treated without revascularizationJ Vasc Surg200644110811416828434
   PubMed Web of Science ®Google Scholar
• RutherfordRBBakerJDErnstCRecommended standards for reports dealing with lower extremity ischemia: revised versionJ Vasc Surg19972635175389308598
   PubMed Web of Science ®Google Scholar
• ConteMSCritical appraisal of surgical revascularization for critical limb ischemiaJ Vasc Surg201357Suppl 28S13S23336860
   PubMedGoogle Scholar
• WolfeJHWyattMGCritical and subcritical ischaemiaEur J Vasc Endovasc Surg19971365785829236711
   PubMed Web of Science ®Google Scholar
• RuedaCANehlerMRPerryDJPatterns of artery disease in 450 patients undergoing revascularization for critical limb ischemia: implications for clinical trial designJ Vasc Surg2008475995999 discussion 999–100018372151
   PubMed Web of Science ®Google Scholar
• HankeyGJNormanPEEikelboomJWMedical treatment of peripheral arterial diseaseJAMA2006295554755316449620
   PubMed Web of Science ®Google Scholar
• JamesPAOparilSCarterBL2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)JAMA2014311550752024352797
   PubMed Web of Science ®Google Scholar
• StoneNJRobinsonJGLichtensteinAH2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesCirculation201412925 Suppl 2S1S4524222016
   PubMed Web of Science ®Google Scholar
• Heart Protection Study Collaborative GroupMRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trialLancet2002360932672212114036
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists’ CollaborationCollaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71–86Erratum in: BMJ20023247330141
   Google Scholar
• CAPRIE Steering CommitteeA randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering CommitteeLancet19963489038132913398918275
   PubMed Web of Science ®Google Scholar
• FokkenroodHJBendermacherBLLauretGJWilligendaelEMPrinsMHTeijinkJASupervised exercise therapy versus non-supervised exercise therapy for intermittent claudicationCochrane Database Syst Rev20138CD00526323970372
   PubMedGoogle Scholar
• GardnerAWPoehlmanETExercise rehabilitation programs for the treatment of claudication pain. A meta-analysisJAMA1995274129759807674529
   PubMed Web of Science ®Google Scholar
• MeierGHCurrent literature for evidence-based infrainguinal endovascular treatmentSemin Vasc Surg200821421021619073312
   PubMed Web of Science ®Google Scholar
• GoodneyPPBeckAWNagleJWelchHGZwolakRMNational trends in lower extremity bypass surgery, endovascular interventions, and major amputationsJ Vasc Surg2009501546019481407
   PubMed Web of Science ®Google Scholar
• JoelsCSYorkJWKalbaughCACullDLLanganEM3rdTaylorSMSurgical implications of early failed endovascular intervention of the superficial femoral arteryJ Vasc Surg200847356256518295107
   PubMed Web of Science ®Google Scholar
• RyerEJTrocciolaSMDeRubertisRAnalysis of outcomes following failed endovascular treatment of chronic limb ischemiaAnn Vasc Surg200620444044616865606
   PubMed Web of Science ®Google Scholar
• AdamDJBeardJDClevelandTBASIL trial participantsBypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trialLancet200536695011925193416325694
   PubMed Web of Science ®Google Scholar
• BradburyAWAdamDJBellJBASIL trial participantsBypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: analysis of amputation free and overall survival by treatment receivedJ Vasc Surg201051Suppl 518S31S20435259
   PubMedGoogle Scholar
• PentecostMJCriquiMHDorrosGGuidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. A statement for health professionals from a special writing group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart AssociationCirculation19948915115318281692
   PubMed Web of Science ®Google Scholar
• TaylorSMYorkJWCullDLKalbaughCACassALLanganEMClinical success using patient-oriented outcome measures after lower extremity bypass and endovascular intervention for ischemic tissue lossJ Vasc Surg2009503534541 discussion 54119592193
   PubMed Web of Science ®Google Scholar
• ConteMSBypass versus angioplasty in severe ischaemia of the leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemiaJ Vasc Surg201051Suppl 569S75S20435263
   PubMedGoogle Scholar
• JensSConijnAPKoelemayMJBipatSReekersJARandomized trials for endovascular treatment of infrainguinal arterial disease: systemic review and meta-analysis (Part 1: Above the knee)Eur J Vasc Endovasc Surg201447552453524656874
   PubMed Web of Science ®Google Scholar
• SimpsonELMichaelsJAThomasSMCantrellAJSystematic review and meta-analysis of additional technologies to enhance angioplasty for infrainguinal peripheral arterial occlusive diseaseBr J Surg201310091128113723842827
   PubMed Web of Science ®Google Scholar
• SchillingerMSabetiSDickPSustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stentingCirculation2007115212745274917502568
   PubMed Web of Science ®Google Scholar
• LairdJRKetzenBTScheinertDRESILIENT InvestigatorsNitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trialCirc Cardiovasc Interv20103326727620484101
   PubMed Web of Science ®Google Scholar
• SchmiederGCRichardsonAIScottECStokesGKMeierGHPannetonJMSelective stenting in subintimal angioplasty: analysis of primary stent outcomesJ Vasc Surg200848511751180 discussion 1180–118118778911
   PubMed Web of Science ®Google Scholar
• BachooPThorpePAMaxwellHWelchKEndovascular stents for intermittent claudicationCochrane Database Syst Rev20101CD00322820091540
   PubMedGoogle Scholar
• MwipatayiBPHockingsAHofmannMGarbowskiMSieunarineKBalloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysisJ Vasc Surg200847246146917950563
   PubMed Web of Science ®Google Scholar
• GeraghtyPJMewissenMWJaffMRAnselGMVIBRANT InvestigatorsThree-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive diseaseJ Vasc Surg2013582386395.e423676191
   PubMed Web of Science ®Google Scholar
• LammerJZellerTHauseggerKAHeparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease)J Am Coll Cardiol201362151320132723831445
   PubMed Web of Science ®Google Scholar
• McQuadeKGableDPearlGTheuneBBlackSFour-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive diseaseJ Vasc Surg2010523584590 discussion 590–591, 591. e1–591.e720598480
   PubMed Web of Science ®Google Scholar
• SiablisDKarnabatidisDKatsanosKSirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefitJ Endovasc Ther200714224125017484536
   PubMed Web of Science ®Google Scholar
• GilesKAPomposelliFBSpenceTLInfrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbsJ Vasc Surg200848112813618502084
   PubMed Web of Science ®Google Scholar
• ConradMFKangJCambriaRPInfrapopliteal balloon angioplasty for the treatment of chronic occlusive diseaseJ Vasc Surg2009504799805.e419786239
   PubMed Web of Science ®Google Scholar
• ConteMSBandykDFClowesAWPREVENT III InvestigatorsResults of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgeryJ Vasc Surg2006434742751 discussion 75116616230
   PubMed Web of Science ®Google Scholar
• ConteMSGeraghtyPJBradburyAWSuggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemiaJ Vasc Surg200950614621473.e119897335
   PubMed Web of Science ®Google Scholar
• MillsJLSrInfrainguinal disease: Surgical treatmentCronenwettJLJohnstonKWRutherford’s Vascular Surgery8th edPhiladelphia, PAElsevier Saunders201417581781
   Google Scholar
• KlinkertPSchepersABurgerDHvan BockelJHBreslauPJVein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trialJ Vasc Surg200337114915512514593
   PubMed Web of Science ®Google Scholar
• JohnsonWCLeeKKA comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative studyJ Vasc Surg200032226827710917986
   PubMed Web of Science ®Google Scholar
• GentileATLeeRWMonetaGLTaylorLMEdwardsJMPorterJMResults of bypass to the popliteal and tibial arteries with alternative sources of autogenous veinJ Vasc Surg1996232272279 discussion 279–2808637104
   PubMed Web of Science ®Google Scholar
• SchanzerAHeveloneNOwensCDTechnical factors affecting autogenous vein graft failure: observations from a large multicenter trialJ Vasc Surg200746611801190 discussion 119018154993
   PubMed Web of Science ®Google Scholar
• HölzenbeinTJPomposelliFBMillerAThe upper arm basilic-cephalic loop for distal bypass grafting: technical considerations and follow-upJ Vasc Surg1995214586592 discussion 592–5947707564
   PubMed Web of Science ®Google Scholar
• LoGerfoFWPaniszynCWMenzoianJA new arm vein graft for distal bypassJ Vasc Surg1987568898913586189
   PubMed Web of Science ®Google Scholar
• PostSKrausTMüller-ReinartzUDacron vs. polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomised multicentre trialEur J Vasc Endovasc Surg200122322623111506515
   PubMed Web of Science ®Google Scholar
• RobinsonBIFletcherJPTomlinsonPA prospective randomized multicentre comparison of expanded polytetrafluoroethylene and gelatin-sealed knitted Dacron grafts for femoropopliteal bypassCardiovasc Surg19997221421810353674
   PubMedGoogle Scholar
• DevineCMcCollumCNorth West Femoro-Popliteal Trial ParticipantsHeparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trialJ Vasc Surg200440592493115557906
   PubMed Web of Science ®Google Scholar
• DevineCHonsBMcCollumCHeparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicenter trialJ Vasc Surg200133353353911241124
   PubMed Web of Science ®Google Scholar
• AaldersGJvan VroonhovenTJPolytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: six-year results of a randomized clinical trialJ Vasc Surg1992166816823 discussion 823–8241460707
   PubMed Web of Science ®Google Scholar
• ScharnDMDirvenMBarendregtWBBollAPRoelofsDvan der VlietJAHuman umbilical vein versus heparin-bonded polyester for femoro-popliteal bypass: 5-year results of a prospective randomized multicentre trialEur J Vasc Endovasc Surg2008351616717936036
   PubMed Web of Science ®Google Scholar
• EickhoffJHBrooméAEricssonBFFour years’ results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal bypassJ Vasc Surg1987655065113669200
   PubMed Web of Science ®Google Scholar
• GreenRMAbbottWMMatsumotoTProsthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trialJ Vasc Surg200031341742510709052
   PubMed Web of Science ®Google Scholar
• AlbersMBattistellaVMRomitiMRodriguesAAPereiraCAMeta-analysis of polytetrafluoroethylene bypass grafts to infrapopliteal arteriesJ Vasc Surg20033761263126912764274
   PubMed Web of Science ®Google Scholar
• GriffithsGDNagyJBlackDStonebridgePARandomized clinical trial of distal anastomotic interposition vein cuff in infrainguinal polytetrafluoroethylene bypass graftingBr J Surg200491556056215122605
   PubMed Web of Science ®Google Scholar
• MillerJHForemanRKFergusonLFarisIInterposition vein cuff for anastomosis of prosthesis to small arteryAust N Z J Surg19845432832856380479
   PubMedGoogle Scholar
• DucasseEChevalierJChevierEPatency and limb salvage after distal prosthetic bypass associated with vein cuff and arteriovenous fistulaEur J Vasc Endovasc Surg200427441742215015194
   PubMed Web of Science ®Google Scholar
• FarberAMajorKWagnerWHCryopreserved saphenous vein allografts in infrainguinal revascularization: analysis of 240 graftsJ Vasc Surg2003381152112844083
   PubMed Web of Science ®Google Scholar
• RandonCJacobsBDe RyckFBeeleHVermassenFFifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvageJ Vasc Surg201051486987720347683
   PubMed Web of Science ®Google Scholar
• TanTWRybinDKalishJAVascular Study Group of New EnglandRoutine use of completion imaging after infrainguinal bypass is not associated with higher bypass graft patencyJ Vasc Surg2014603678685.e224721174
   PubMed Web of Science ®Google Scholar
• LundellALindbladBBergqvistDHansenFFemoropopliteal-crural graft patency is improved by an intensive surveillance program: a prospective randomized studyJ Vasc Surg19952112633 discussion 33–347823359
   PubMed Web of Science ®Google Scholar
• VisserKIduMMButhJEngelGLHuninkMGDuplex scan surveillance during the first year after infrainguinal autologous vein bypass grafting surgery: costs and clinical outcomes compared with other surveillance programsJ Vasc Surg200133112313011137932
   PubMed Web of Science ®Google Scholar
• TangelderMJAlgraALawsonJAHennekesSEikelboomBCOptimal oral anticoagulant intensity to prevent secondary ischemic and hemorrhagic events in patients after infrainguinal bypass graft surgery. Dutch BOA Study GroupJ Vasc Surg200133352252711241122
   PubMed Web of Science ®Google Scholar
• GeraghtyAJWelchKAntithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgeryCochrane Database Syst Rev20116CD00053621678330
   PubMedGoogle Scholar